使用甲胺增强CRISPR/Cas9基因编辑
Jaedyn L Rollins1, Raquel M Hall1, Clara J Lemus1
1Washington Square, Department of Biological Sciences, San José State University, San José, CA, 95112, USA.
Biochemistry and biophysics reports
|September 18, 2023
概括
美国食品和药物管理局 (FDA) 批准的一种药物梅特福明 (Metformin) 提高了血造干细胞 (HSC) 中的CRISPR/Cas9基因编辑效率. 这项研究表明,甲胺可以改善DNA切割和向,这为促进治疗血液疾病的基因修饰提供了潜在的策略.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 血液学 血液学 血液学
背景情况:
- 克里斯普尔/Cas9技术使基因组编辑成为可能,在纠正单一性血液疾病和开发免疫疗法方面有潜在的应用.
- 血造干细胞 (HSC) 编辑效率目前是治疗应用的重大限制.
- 甲胺是一种FDA批准的药物,有可能提高基因修改效率.
研究的目的:
- 为了研究甲胺在增强血造细胞系中CRISPR/Cas9基因编辑的疗效.
- 评估甲胺对CRISPR/Cas9的切割和准效率的影响.
- 为了确定甲胺是否可以改善与血液疾病相关的细胞中的基因修饰.
主要方法:
- 评估了甲福明对K562 (骨髓) 和Jurkat (淋巴细胞) 细胞系生长的影响.
- 用0.001毫米和1毫米度的甲福明治疗细胞.
- 评估了使用五个引导RNA的CRISPR/Cas9切割效率和使用含有GFP的DNA修复模板的准效率.
主要成果:
- 在高达10毫米的度下,甲福明并没有显著影响K562或Jurkat细胞的生长.
- 甲素显著提高了Cas9的切割效率,以切割血小板和红细胞位点.
- 观察到GFP表达量增加了两倍以上,这表明甲福林治疗增强了基因向.
结论:
- 甲胺可以显著提高CRISPR/Cas9基因编辑的切割和准效率.
- 研究结果表明,可以将甲胺纳入现有方案,以改善血液细胞的基因修饰.
- 甲胺是一种有前途的,FDA批准的治疗补充剂,用于推进基于CRISPR/Cas9的血液疾病基因疗法.
更多相关视频
10:07A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
7.9K
11:35Selection-dependent and Independent Generation of CRISPR/Cas9-mediated Gene Knockouts in Mammalian Cells
Published on: June 16, 2017
12.6K
相关概念视频
01:28CRISPR/Cas9 Genome Editing
48
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
48
01:59CRISPR
52.2K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.2K
02:31Homologous Recombination
50.6K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.6K